APA (7th ed.) Citation

WS, H., & CL, L. (2025). Impact of sacubitril/valsartan on adverse clinical events in heart failure with end-stage renal disease patients-a real life nationwide investigation. Naunyn-Schmiedeberg's archives of pharmacology, 398(11), 15391. https://doi.org/10.1007/s00210-025-04223-7

Chicago Style (17th ed.) Citation

WS, Hu, and Lin CL. "Impact of Sacubitril/valsartan on Adverse Clinical Events in Heart Failure with End-stage Renal Disease Patients-a Real Life Nationwide Investigation." Naunyn-Schmiedeberg's Archives of Pharmacology 398, no. 11 (2025): 15391. https://doi.org/10.1007/s00210-025-04223-7.

MLA (9th ed.) Citation

WS, Hu, and Lin CL. "Impact of Sacubitril/valsartan on Adverse Clinical Events in Heart Failure with End-stage Renal Disease Patients-a Real Life Nationwide Investigation." Naunyn-Schmiedeberg's Archives of Pharmacology, vol. 398, no. 11, 2025, p. 15391, https://doi.org/10.1007/s00210-025-04223-7.